Development of Farnesyltransferase Inhibitors for Clinical Cancer Therapy: Focus on Hematologic Malignancies

By Karp Judith   Lancet Jeffrey  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 484-494

Informa Healthcare

Access to resources Recommend Favorite

Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects

By Prendergast G.C.   Oliff A.  

Seminars in Cancer Biology, Vol. 10, Iss. 6, 2000-12 ,pp. : 443-452

Academic Press

Access to resources Recommend Favorite

Farnesyltransferase inhibitors as radiation sensitizers

By Brunner T. B.   Gupta A. K.   Shi Y.   Hahn S. M.   Muschel R. J.   McKenna W. G.   Bernhard E. J.  

International Journal of Radiation Biology, Vol. 79, Iss. 7, 2003-07 ,pp. : 569-576

Informa Healthcare

Access to resources Recommend Favorite

Adenovirus/PSA (Ad5-PSA) Vaccination for Prostate Cancer: Pre-Clinical and Clinical Development

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 271-273

Bentham Science Publishers

Access to resources Recommend Favorite

Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping

By Tanaka Eiichi   Choi Hak   Fujii Hirofumi   Bawendi Moungi   Frangioni John  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1671-1681

Springer Publishing Company

Access to resources Recommend Favorite